OTC Markets OTCQX - Delayed Quote USD
Integrated BioPharma, Inc. (INBP)
0.2900
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
52,124
50,317
50,672
56,246
63,559
Cost of Revenue
47,050
46,433
46,611
49,694
54,079
Gross Profit
5,074
3,884
4,061
6,552
9,480
Operating Expense
3,625
3,633
3,941
3,807
3,696
Operating Income
1,449
251
120
2,745
5,784
Net Non Operating Interest Income Expense
33
18
-14
-128
-256
Other Income Expense
-27
-1
-6
-20
1,719
Pretax Income
1,455
268
100
2,597
7,247
Tax Provision
527
156
134
-1,241
-766
Net Income Common Stockholders
928
112
-34
3,838
8,013
Diluted NI Available to Com Stockholders
928
112
-34
3,838
8,013
Basic EPS
0.03
0.00
-0.00
0.13
0.27
Diluted EPS
0.03
0.00
-0.00
0.12
0.25
Basic Average Shares
30,118.1900
30,066.0030
29,949.6100
29,699.0650
29,699.0650
Diluted Average Shares
31,262.5000
30,873.6810
29,949.6100
32,113.6810
32,113.6810
Total Operating Income as Reported
1,449
251
120
2,745
5,784
Total Expenses
50,675
50,066
50,552
53,501
57,775
Net Income from Continuing & Discontinued Operation
928
112
-34
3,838
8,013
Normalized Income
928
112
-34
3,881.4500
6,799.7400
Interest Expense
--
--
40
107
214
Net Interest Income
33
18
-14
-128
-256
EBIT
1,449
251
120
2,704
7,461
EBITDA
2,708
1,472
1,274
3,538
8,287
Reconciled Cost of Revenue
47,050
46,433
46,611
49,694
54,079
Reconciled Depreciation
1,259
1,221
1,154
834
826
Net Income from Continuing Operation Net Minority Interest
928
112
-34
3,838
8,013
Total Unusual Items Excluding Goodwill
--
--
-8
-55
1,662
Total Unusual Items
--
--
-8
-55
1,662
Normalized EBITDA
2,708
1,472
1,274
3,593
6,625
Tax Rate for Calcs
0.0004
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
0
0
0
-11.5500
448.7400
6/30/2021 - 10/30/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade